2020 Annual Global Meeting - IGCS xDigital 2020...2020/09/03 · Muhieddine Seoud (Lebanon), Ali Ayhan (Turkey) 12:30— 13:30 Presidential Plenary IV Presidential Address, Advocacy

2020 Annual Global Meeting of the International Gynecologic Cancer Society

PROGRAM

CONTENTS

MEETING INFORMATION

Welcome Letter

General Information

Social Media #IGCS2020

CME/CPD Accreditation

Program at a Glance

Surgical Film Cinema

IGCS Business Meeting Agenda

Women4Women Concert

SCIENTIFIC PROGRAM

Thursday, September 10, 2020

Friday, September 11, 2020

Saturday, September 12, 2020

Sunday September 13, 2020

RECOGNITION, ACKNOWLEDGEMENTS & INDUSTRY SUPPORT

Industry Sponsors

IGCS Award Recipients

IJGC Award Recipients

IGCS Strategic Alliance Partners

IGCS Organizational Partners and Strategic Advocacy Partners

IGCS Council

IGCS Staff

Save the Date for Rome 2021

igcsmeeting.com

WELCOME LETTER

Dear Colleagues:

On behalf of the Scientific Program Committee, we are pleased to bring you the 2020 IGCS Annual Global Meeting utilizing the most innovative interactive “xDigital” technology platform designed to truly immerse you into the meeting experience from the comfort of your home or office.

Despite the challenges of the pandemic, IGCS is committed to virtually provide our members and delegates around the world with targeted educational programming, the latest scientific research in gynecologic cancers, and interactive networking opportunities. The IGCS leadership, dedicated staff and our new digital technology partner, iCrossing has risen to the occasion, making every effort to transition the IGCS Meeting into an online environment to fulfil the mission of our society. We are overwhelmed and grateful for the support of our course directors, expert faculty, abstract presenters, and industry partners who have worked tirelessly to contribute to our program in an accelerated timeline.

Following the tradition of previous meetings, IGCS 2020 will provide you with the opportunity to learn about the latest clinical advances as well as international developments in research, practice, and treatment for the care of women affected by gynecological cancer. Concurrent educational programming will run on four channels at different times each day to ensure that our delegates in all parts of the world are able to participate in parts of the program. Many of the live sessions with have opportunities for audience participation through Q&A segments and polling.

In addition to the scheduled programming, we are thrilled to offer 24-hour access to the Meeting Portal where delegates can access the Digital Exhibition Hall for the latest updates and technology from our industry partners, the Surgical Film Cinema which contains 21 films, the Abstract Poster Hall with over 300 posters and nearly 50 audio files where the poster authors further explain their research and the IGCS Link which allows delegates to send personal messages to each other.

The Meeting Portal will remain open 10 days after the meeting until September 24th, giving delegates the opportunity to watch recordings of the educational sessions and to access all the other features mentioned above.

Perhaps now more than ever, it is important for the gynecologic oncology community to utilize novel virtual solutions to share research for the sake of caring for patients with gynecologic malignancies. IGCS has always served to unite the globe in the fight against gynecologic cancers.

Sincerely,

Roberto Angioli, MD 2018-2020 IGCS President

Thomas Herzog, MD 2020 IGCS Scientific Committee Co-Chair

Rainer Kimmig, MD 2020 IGCS Scientific Committee Co-Chair

http://www.igcsmeeting.com

GENERAL INFORMATION

Meeting Access

IGCS xDigital Meeting Delegates may access the Meeting Portal at www.igcsmeeting.com and login with the information provided via email.

Exhibition Times The Digital Exhibition Hall will be open 24 hours throughout the duration of the Meeting starting on September 10, 2020 at 14:00 UTC and ending on September 13, 2020 at 06:00 UTC. The Meeting Portal will remain open for 10 days after the meeting (until September 24, 2020) and delegates may continue to access the exhibit hall while the Meeting Portal is open.

Meeting Abstracts All the Meeting abstracts are available on the Interactive Online Program on the Meeting Website at igcsmeeting.com. The IGCS 2020 Meeting Abstracts will also be published in the International Journal of Gynecological Cancer after the meeting.

Company & Exhibition Guide In accordance with compliance regulations, Industry supporting the Meeting will be acknowledged separately from the Scientific Program. It will appear at the back of the program e-book, under the section RECOGNITION, ACKNOWLEGEMENTS, AND INDUSTRY SUPPORT

Frequently Asked Questions For detailed answers to questions you may have, please click here.

Meeting Organizers

International Gynecologic Cancer Society and iCrossing, a Hearst Company

Support Contacts for Delegates

• Delegates who require assistance accessing the Meeting Portal, email: [email protected]

• Delegates who require assistance within the Meeting Portal, please access the 24-hour chat service found within the portal via IGCS Link

https://igcsmeeting.com/faqs/

mailto:[email protected]

GET SOCIAL! Follow the official meeting hashtag and

share your insights on social media:

#IGCS2020

https://www.facebook.com/igcs.org/

https://www.instagram.com/igcsociety/

https://twitter.com/igcsociety

https://www.linkedin.com/company/igcs/

CONTINUING MEDICAL EDUCATION

EDUCATIONAL OBJECTIVES

After participating in this educational event, learners should be able to:

• Address individual needs in compliance with their Continuous Professional Development (CPD) plan.

• Describe the latest information in treatment strategies in gynaecologic cancers.

• Identify educational resources, networks and other for exchange of knowledge and learning about gynaecological cancer.

• Discuss translational research and clinical trials in gynecological cancers.

• Address novelties in surgery, radiotherapy, chemotherapy and immunotherapy in the treatment of gynecological malignancies.

TARGET AUDIENCE IGCS 2019 is the global meeting place for clinical practitioners, researchers, clinical researchers in the field of gynecological oncology and its sub-specialties. INDUSTRY SUPPORT DISCLOSURE This event is supported, in part, by funding from industry. All support is managed in strict accordance with CME/CPD accreditation criteria and standards for commercial support. Appropriate acknowledgement of all supporting organizations is made in the program guide and on the event website

• A list of all industry supporters and sessions is available in the Recognition, Acknowledgements and Industry Support section at the back of this program book.

• Detailed programs for all Industry Sessions are available on the Online Program

E ACCREDITATION The xDigital IGCS Annual Global Meeting has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with: 12 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.” Below the breakdown of ECMEC®s per day:

September 10 - 3.00 September 11 - 3.00 September 12 - 3.00 September 13 - 3.00

AMERICAN MEDICAL ASSOCIATION (AMA) Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at https://edhub.ama-assn.org/pages/applications ROYAL COLLEGE OF PHYSICIANS AND SURGEONS OF CANADA Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada.

TO RECEIVE YOUR CME/CPD CERTIFICATE The CME/CPD certificate will be available after completing the online evaluation and credit claiming procedure. The process takes about 10 minutes. We thank you for your feedback as it is an important part of CME/CPD accreditation and helps improve future educational offerings.

Before September 15,2020:

1. - Visit the CME/CPD Accreditation page on the event website and click on the following link: EVALUATION FORM Please note that web browsers Mozilla Firefox 2.X or higher, or Google Chrome are recommended. 2. Complete the online evaluation form 3. Once completed submit your form 4. The CME/CPD certificate will be sent via email once received the form duly filled in. CME PROVIDER ID 836 Via Flaminia Vecchia, 508 00191 Roma- Italy e-mail: [email protected] www.bluevents.it

Universal Coordinated Time (UTC)

13:00—14:00

ANIA Foundation Symposia Medmal Insurance: Risk & Safety

14:00—15:00

Opening Ceremony & Awards Plenary I: Oral Abstract Presentations

15:00—16:00

Plenary II: Oral Abstract Presentations

16:00—17:00

Debate your Colleague Ovary Surgical Reduction for Reoccurrence Moderator: Audrey Tsunoda (Brazil) GOG 213—Robert Coleman (USA) Vs Desktop III—Andreas Du Bois (Germany)

Surgical Film Educational: Managing Complications

Chairs: Mario Leitao (USA) Vance Broach (USA)

17:00—18:15

Industry Symposia (Astrazeneca) Redefining expectations in the era of personalised medicine: maintenance therapy in newly diagnosed ovarian cancer

Schedule at a Glance

Thursday, September 10, 2020

CHANNEL 1 LIVE

CHANNEL 1 LIVE

CHANNEL 1 LIVE

CHANNEL 1 LIVE

CHANNEL 3

Plenary Session Master Session Debate your Colleague

Surgical Film

Industry Symposia Postgraduate Education

Oral Featured Posters Tumor Board

PROGRAM AT A GLANCE

CHANNEL 1 CHANNEL 2 CHANNEL 3 CHANNEL 4

CHANNEL 1 LIVE

1 CME

1 CME

1 CME


11:00—12:00

Plenary III : Oral Abstract Presentations

12:00—13:00

Master Session: Ovarian Cancer

Chairs: Robert Coleman (USA), Nicoletta Colombo (Italy), Douglas Levine (USA)

Debate your Colleague: HIPEC in Ovarian Cancer—Ready for Primetime?

Moderator: Keiichi Fujiwara (Japan)Pro: Willemien van Driel (The Netherlands) Con: Christian Marth (Austria)

Surgical Films: SERGS—Sentinel Lymph Node Biopsy in Gynecologic Oncology Surgical Films

Chairs: Henrick Falconer (Sweden), Thomas Ind (UK)

Preinvasive Disease of the Lower Genital Tract

Chairs: Mila Salcedo (Brazil), Joseph Ng (Singapore), Kathleen Schmeler (USA), Ida Ismail-Pratt (Singapore)

13:00—14:30

Tumor Board

Chairs: R. Wendel Naumann (USA), Donal Brennan (Ireland)

14:30—16:00

Industry Symposium (Novocure) The Role of Tumor Treatment Fields in the Management of Recurrent Ovarian Cancer

Industry Symposium (GlaksoSmithKline) PARP Inhibitors in the Maintenance Treatment of Advanced Ovarian Cancer: Shared Decision Making, Patient Perspectives

16:00—17:00

Industry Symposium (Intuitive Surgical) Perspectives on the place of da Vinci robotic assisted surgery in the surgical management of endometrial cancer patients

17:00—18:00

Women4Women Concert


Friday, September 11, 2020

CHANNEL 1 LIVE

CHANNEL 1 LIVE

CHANNEL 1 LIVE

CHANNEL 1 LIVE

CHANNEL 2 LIVE

CHANNEL 2 LIVE

CHANNEL 2

CHANNEL 3 CHANNEL 4

CHANNEL 1 LIVE

1 CME

1 CME

1 CME

1 CME


11:00—12:30

Master Session: Vulvar Cancer

Chairs: Michael Höckel (Germany), Benedetti Panici (Italy), Ate van der Zee (The Netherlands)

Immunotherapy in the Management of Gynecologic Cancers

Chair: Amir Jazaeri (USA)

Surgical Films Ovarian Cancer

Chairs: Christina Fotopoulou (UK), Reitan Ribeiro (Brazil)

The Role of the Gyn Oncologist in the Management of Obstetrical Disasters

Chairs: David Attalah (Lebanon), Muhieddine Seoud (Lebanon), Ali Ayhan (Turkey), Faruk Kose (Turkey)

12:30—13:30

Presidential Plenary IV Presidential Address, Advocacy Panel, Business Meeting

13:30—14:30

Master Session: Uterine Cancer

Chairs: Pernille Jensen (Denmark), Andrea Mariani (USA), Matthew Powell (USA)

Cancer Care in Africa

Chairs: Elkanah Omenge (Kenya), Orang'o, Jane Namugga (Uganda)

Oral Featured Posters

Surgical Films ESGE

Chairs: Giovanni Scambia, I(taly) Sven Becker (Germany)

14:30—15:30

GTD: State of the Art Management of High-Risk, & Recurrent/Refractory Disease

Chairs: John Soper (USA), Neil Horowitz (USA)

An Update on the WHO Classification of Tumors of the Female Genital Tract

15:30—16:30

Industry Symposium (Immunogen) Promising Agents In Development For Recurrent Ovarian Cancer (1 hr)

Industry Symposium (Myriad) Title to be announced (0.75 hr)


Saturday, September 12, 2020

CHANNEL 1 LIVE

CHANNEL 2 LIVE

CHANNEL 2

CHANNEL 2

CHANNEL 4

CHANNEL 1 LIVE

CHANNEL 1 LIVE

CHANNEL 1 LIVE

CHANNEL 4

CHANNEL 4 CHANNEL 3

CHANNEL 3

CHANNEL 2

1 CME 1 CME

1 CME

1 CME 2 CMEs


2:00—3:00

Cancer Field Surgery for Gynecologic Malignancies

Chairs: Michael Höckel (Germany), Rainer Kimmig (Germany)

Oral Featured Posters

Surgical Films Cervical Cancer & Fertility Preservation

Chair: Jae-Weon Kim (Rep. of Korea)

Master Session Cervix Cancer

Chairs: Bradley Monk (USA), Mary McCormack (UK), Ana Oaknin (Spain)

3:00—5:00

5:00—6:00

Plenary V: Oral Abstract Presentations

6:00—7:30

Regional Session: Korean Society of Gynecologic Oncology (KSGO)

Chairs: Seung-Cheol Kim, Jae-Weon Kim, Young-Tak Kim, Young-Tae Kim

7:30—9:00

Regional Session: Japanese Society of Gynecologic Cancer (JSGO)

Chairs: Fuminori Taniguchi, Daichi Maede, Ken Yamaguchi, Hiroaki Kajiyama, Noriomi Matsumura

CHANNEL 1 LIVE

CHANNEL 1 LIVE

CHANNEL 1 LIVE

CHANNEL 2 LIVE CHANNEL 3


Sunday, September 13, 2020

CHANNEL 1 LIVE

CHANNEL 1 LIVE

1 CME

3 CMEs 2 CMEs

SURGICAL FILM CINEMA

Laparoscopic Management Of Huge Ovarian Cyst; Novel Technique S. Addley, H. Soleymani Majd, M. Alazzam

VNOTES (Vaginal Natural Orifices Transluminal Endoscopic Surgery) For Ia1 Cervical Carcinoma. L. Badiglian-Filho, C. Chaves Faloppa, E. Mieko Fukazawa, G. Baiocchi, L. Badiglian-Filho, C. Chaves Faloppa, E. Mieko Fukazawa, G. Baiocchi Laterally Extended Parametrectomy (LEP) M. Capilna, S.L. Kiss, A. Cozlea, M. Stanca, M. Gheorghes

Laparoscopic Primary Repair Of Duodenal Perforation After Laparoscopic Para-Aortic Lymphadenectomy J.S. Choi

Laparoscopic Resection Of Bulky Para-Aortic Lymph Node Metastasis J.S. Choi

Extraperitoneal Laparoscopic Pelvic Lymphadenectomy For Cervical Cancer Staging In Twin Pregnancy M. Corinti, V. Bezerra, R. Ribeiro, A. Liao, S. Podgaec, R. Moretti-Marques

Laparoscopic Approach For Cervical Or Vaginal Malignancies In Patients With Previous Histerectomy. A Report Of Three Cases M.C. Darin, J. di Guilmi, P. Piaquadio, R. Rampulla, A.G. Maya

Secondary Laparoscopic Cytoreduction For Recurrent Ovarian Cancer In Case Of Laparoscopic Primary Debulking Surgery J.M. Eom Resection Of Perianal Cis With V-Y Graft Reconstruction K. Hatch

Robotic Assited Inguinpfemoral Lymphadenectomy For Vulval Carcinoma Y. Kulkarni, A. Pednekar

Standard Laparoscopic Bilateral Pelvic Sentinel Lymph Node Detection With Radiotracer, Blue Dye And Permanent Instruments A. Munhóz, I. Nascimento, J. Linhares, R. Ribeiro, A. Tsunoda

SURGICAL FILM CINEMA

Robotic Ileal Neovagina R. Ribeiro, A. Munhóz, H.K. Rabelo, A. Vargas, A. Tsunoda, J. Linhares Robotic Assisted Laparoscopic Resection Of Rectovaginal Clear Cell Carcinoma Mass Arising From Endometriosis M. White, F. Nezhat Uterine Transposition In A Case Of Rectal Malignancy M. OBrien, F. Donohoe, B. Boyd, R. McVey, T. Walsh, A. Brannigan, D. Brennan Surgery For Rectosigmoid Peritonectomy In Advanced Ovarian Cancer: Surgical Technique Of Visceral Segmental Serosectomy And 8-Year Experience S.J. Park, H.S. Kim, J.W. Kim Laparoscopic Approach To Bulky Pelvic Lymph Nodes: Tips And Ticks R. Ribeiro, C.O. Pereira, G.A. Polaquini, A. Munhoz, J.C. Linhares, A.T. Tsunoda Minimally Invasive Bleeding Management During Pelvic Lymphadenectomy R. Ribeiro, B. Real, R. Lyria, A. Munhoz, A. Tsunoda, J. Guerreiro Retroperitoneal Bleeding Management During Laparoscopic Lymphadenectomy J. Ribeiro, S. Testa Laparoscopic Nerve Sparing Radical Hysterectomy: Measure To Prevent Tumor Spillage For Better Prognosis And Preservation Of Voiding Function Based On Clinical Pelvic Anatomy Y. Shiki, S. Higami, M. Terada, T. Deguchi, M. Shiraishi, Y. Tanaka, A. Hosoi, S. Koyama Laparoscopic Assisted Infralevator Posterior Exenteration With Vulvovaginal Reconstruction T.S. Shylasree, P. Poddar, M. Bhandare, D. Jaiswal, P. Popat, S. Menon Techniques Of Quadrant Wise Cytoreductive Surgery In Advanced Epithelial Ovarian Cancer : Total Parietal Peritonectomy + Retrograde Hysterectomy + Mesentric Stripping & Glissons Capsulectomy S.P. Somashekhar, C. Rohit Kumar, K.R. Ashwin

IGCS ANNUAL BUSINESS MEETING

Saturday, September 12, 2020 8:30 AM CDT USA | 1:30 PM UTC

Channel 1

Agenda

1. Welcome

Dr. Roberto Angioli IGCS 2018-2020 President

2. Secretary-Treasurer Report

Dr. Andreas Obermair IGCS Secretary-Treasurer

3. International Journal of Gynecological Cancer Report

Dr. Pedro Ramirez IJGC Editor in Chief

4. Membership Report


5. Patient Advocacy

Ms. Dicey Scroggins IGCS Director of Global Outreach & Engagement

6. Education Committee Report

Dr. Ritu Salani Chair, IGCS Education Committee

7. Mentorship & Training Committee Report

Dr. Kathleen Schmeler, Chair, IGCS Mentorship & Training Committee

8. New Business


9. Ceremonial Transition: Dr. Robert Coleman, Incoming President

Dr. Robert Coleman IGCS 2020-2022 President

10. Adjournment

Dr. Robert Coleman IGCS 2020-2022 President

WOMEN4WOMEN CONCERT

Incanto di Venere

Set List: Con te partirò | Habanera – Carmen | Caruso | Once upon the time in America | The Gladiator

Band of the Guardia di Finanza Set List: Aida | Ennio Morricone Medley from Western Movies | Nessun Dorma -

Turandot

Friday, September 11, 2020 12:00pm CDT | 5:00pm UTC (1 hr.)

Channel 1

We are pleased to present the IGCS 2020 delegates with a special concert featuring renowned European Performers.

After the educational sessions on Friday, September 11, we encourage delegates to join us for the Women4Women concert which combines the vocal interweaving of four eclectic sopranos

(Incanto Quartet) and the refined instrumental fabric of strings and piano (Venere Ensemble).

MEMBER BENEFITS

Professional Journal The International Journal of Gynecological Cancer (IJGC) publishes original research, editorials, case studies, and more related to the treatment of gynecologic malignancies with a focus on international perspectives. Video articles and weekly podcasts enhance the learning experience.

Education Portal Enhance your learning with the IGCS Member Education Portal, an online library with recorded presentations from IGCS meetings, surgical videos and specialized content developed by the IGCS Education Committee. Visit the Literature Library (In the Know) to browse a monthly compilation of abstracts and significant literature related to gynecologic oncology.

SurgeryU Video Library SurgeryU delivers high-quality, peer-reviewed surgical videos to members of the AAGL and partner societies such as the IGCS through a live and on-demand video library. The library contains over 1200 surgical videos to educate gynecologic surgeons of all levels on minimally invasive surgical techniques.

Network & Collaborate The IGCS Member Community – Social Link – connects you with over 3200 IGCS members around the world. Search the directory to locate colleagues and use the member forums to discuss ideas, ask questions, and share information about clinical cases, best practices, the latest research findings in gynecologic cancers, and more.

Project ECHO ® Participate in one of our regularly scheduled virtual tumor board video conferences held in various sites around the globe to discuss clinical cases and hear short lectures on a variety of topics. Join a session as a learner or take the opportunity to present a challenging case to gain valuable insights. More experienced members may participate as expert faculty contributors.

Professional Development The IGCS Early Career Research & Publication Network connects experienced mentors with young doctors who completed training within the last five years to develop and promote research project ideas and discuss publications and scientific writing as a critical component of career development via online discussion boards, video conferencing, and in-person meetings.

Advocacy, Outreach & Engagement IGCS unites advocates, advocacy groups, and professional societies around the world to strengthen our voices as we call for improved access to quality health care and empower women with tools and resources to increase their health care autonomy and enable them to act on the specific needs within their region.

IGCS Annual Global Meeting Take advantage of discounted registration to attend the IGCS meeting held in different global regions. Meeting participation is an excellent way to learn about issues affecting the profession, meet experts in the field, present your research, gain inspiration and participate in important initiatives.

Voting Rights & Leadership Opportunities Cast your vote to elect IGCS Council Members every two years and take advantage of opportunities for involvement and leadership within the Society. Apply for a seat on the Council or volunteer to serve on one of IGCS’s Committees or Work Groups.

Full Membership is open to gynecologists, gynecologic oncologists, medical oncologists, radiation oncologists, pathologists, fellows in training, nurses, physician assistants, data managers, clinical research associates or other clinical specialists, physicians or scientists with a major interest in the prevention, treatment or study of gynecologic cancer.

https://igcs.org/ijgc/







https://igcs.org/education-highlights/









https://igcs.org/education-resources/surgeryu/







https://igcs.org/social-link/








https://igcs.org/mentorship-and-training/project-echo/









https://igcs.org/mentorship-and-training/research-publications-network/









https://igcs.org/advocacy/








https://www.igcsmeeting.com/







2020 Virtual Advocacy Survivor-Caregiver Public Summit

Women4Women

Saturday, September 26 8:00 am—12:00 pm CST

Gynecologic Cancer Literacy

Survivorship 101

The Power of Patient Advocacy

Survivors and caregivers from all around the world will gather online for a 4-hour Summit where gynecologic cancer experts, survivors, and advocates will

discuss the science, survivorship, and advocacy.

Registration is FREE. Learn more about the summit and sign up today to reserve your virtual seat.

igcs.org/2020-virtual-advocacy-summit

Promoted and hosted by the International Gynecologic Cancer Society.

https://igcs.org/virtual-advocacy-2020/

https://igcs.org/virtual-advocacy-2020/

https://igcs.org/2020-virtual-advocacy-summit/


SCIENTIFIC PROGRAM

IGCS 2020 SCIENTIFIC PROGRAM

THURSDAY, SEPTEMBER 10

THURSDAY, SEPTEMBER 10, 2020 13:00 – 18:30 UTC CHANNEL 1

ANIA FOUNDATION SYMPOSIA 13:00 – 14:00 UTC

OPENING CEREMONY & AWARDS 14:00 – 14:30 UTC 14:00 WELCOME

Chairs: Thomas Herzog (USA), Rainer Kimmig (Germany) IGCS President: Roberto Angioli (Italy)

14:05 IGCS AWARDS CEREMONY Roberto Angioli (Italy)

PLENARY I: ORAL ABSTRACT PRESENTATIONS 14:30 – 15:00 UTC

14:30 Welcome Nicoletta Colombo (Italy)

14:31 IGCS20_1256: Avelumab in combination with and/or following chemotherapy vs chemotherapy in treatment-naive patients with ovarian cancer: biomarker analyses from the phase 3 JAVELIN Ovarian 100 trial J. Ledermann, N. Colombo, A. Oza, K. Fujiwara, M.J. Birrer, L. Randall, E. Poddubskaya, G. Scambia, Y.V. Shparyk, M.C. Lim, S.M Bhoola, J. Sohn, K. Yonemori, R.A. Stewart, X. Zhang, J. Perkins Smith, C. Linn, B.J. Monk

14:39 IGCS20_1255: Efficacy and Safety of Lenvatinib Plus Pembrolizumab in Patients with Previously Treated Ovarian Cancer in the Multicohort Phase 2 LEAP-005 Study A. González-Martín, H. Chung, E. Saada-Bouzid, E. Yanez, H. Senellart, P.A. Cassier, B. Basu, R. Ghori, P. Kubiak, A. Smith, K. Norwood, Z. Lwin

14:47 IGCS20_1268: Postprogression Efficacy Outcomes From the Phase 3 ARIEL3 Study of Rucaparib in Patients With Platinum-Sensitive Recurrent Ovarian Carcinoma Associated With Either BRCA1 or BRCA2 Mutations J. Weberpals, A. Oza, D. Lorusso, G. Scambia, C. Aghajanian, A. Oaknin, A. Dean, N. Colombo, A.R. Clamp, A. Leary, R.W. Holloway, M. Amenedo Gancedo, P.C. Fong, J.C. Goh, D.M. O’Malley, D.K. Armstrong, S. Banerjee, J. García-Donas, E.M. Swisher, T. Cameron, L. Maloney, S. Goble, R.L. Coleman, J.A. Ledermann

14:54 Distillation Kathleen Moore (USA)



PLENARY II: ORAL ABSTRACT PRESENTATIONS 15:00 – 16:00 UTC

15:00 Welcome Moderator 1: Matthew Powell (USA)

15:01 IGCS20_1447: Refining Pathologic Interpretation of Endometrial Carcinomas: Lessons Learned from a Nationwide Study in a new Era of Molecular Classification E. Thompson, J. Huvila, S. Leung, J. Irving, N. van der Westhuizen, M. Kinloch, A. Lytwyn, M. Sur, C. Parra-Herran, A. Yasmeen, F. Gougeon, C. Morin, K. Grondin, S. Offman, T. Salisbury, E. He, J. Lawson, J. Vanden Broek, C. Bell, K. Ennour-Idrissi, C. Wohlmuth, D. Vicus, D. Vicus, W. Gotlieb, L. Helpman, A. Lum, J. Senz, D. Huntsman, B. Gilks, J.N. McAlpine

15:09 IGCS20_1251: Understanding the clinical implication of mismatch repair deficiency in endometrioid endometrial cancer through a prospective study S. Kim, A. Tone, A. Pollett, R. Kim, M. Cesari, B. Clarke, L. Eiriksson, T. Hart, S. Holter, A. Lytwyn, M. Maganti, L. Oldfield, T. Pugh, S. Gallinger, M. Bernardini, A. Oza, V. Dube, J. Lerner-Ellis, E. Van de Laar, D. Vicus, S. Ferguson

15:17 IGCS20_1049: Variation in practice in endometrial cancer (EC); can molecular classification direct care and reduce costs associated with management? E. Thompson, A. Lum, J. Huvila, S. Scott, V. Lui, E. He, T. Salisbury, S. Keane, S. Keane, V. Samouelian, J. Irving, S. Salvador, L. Helpman, C. Wohlmuth, M. Kinloch, S. Offman, D. Vicus, K. Grondin, W. Gotlieb, M. Plante, D. Huntsman, A. Talhouk, C.B. Gilks, G. Hanley, J. McAlpine

15:25 Distillation Carien Creutzberg (The Netherlands)

Moderator 2: Rene Pareja (Colombia)

15:30 IGCS20_1231: Sentinel lymph node biopsy versus lymphadenectomy for intermediate and high grade endometrial cancer staging (SENTOR trial): A prospective multicenter cohort study M. Cusimano, D. Vicus, K. Pulman, M. Q. Bernardini, G. Bouchard-Fortier, S. Laframboise, T. May, L. Hogen, A. Covens, L.T. Gien, R. Kupets, M. Rouzbahman, B.A. Clarke, J. Mirkovic, M. Cesari, G. Turashvili, M. Maganti, A. Zia, G.E.V. Ene, S. Ferguson

15:38 IGCS20_1246: A multicentric randomized trial to evaluate the ROle of uterine MANipulator on laparoscopic/robotic HYsterectomy for the treatment of low-risk endometrial cancer: the ROMANHY Trial (NCT:02762214) S. Gueli Alletti, E. Perrone, C. Fedele, G. Vizzielli, A. Fagotti, V. Gallotta, C. Rossitto, B. Costantini, S. Restaino, G. Monterossi, F. Fanfani, G. Scambia, S. Cianci, V. Chiantera, S. Uccella, A. Ercoli

15:46 IGCS20_1423: Frailty is Independently Associated with Worse Outcomes and Increased Resource Use Following Procedures to Treat Endometrial Cancer M. Nakhla, A. Mandelbaum, R. Salani, J. Cohen, P. Benharash



15:54 Question & Answer

15:59 Closing Comments

DEBATE YOUR COLLEAGUE: OVARY SURGICAL REDUCTION FOR REOCURRENCE 16:00 – 17:00 UTC

16:00 Introduction Moderator: Audrey Tsunoda (Brazil)

16:05 GOG 213 Robert Coleman (USA)

16:20 Rebuttal Andreas DuBois (Germany)

16:23 Desk Top III Andreas du Bois (Germany)

16:38 Rebuttal Robert Coleman (USA)

16:41 Comments Audrey Tsunoda (Brazil)


INDUSTRY SYMPOSIA: AstraZeneca Redefining expectations in the era of personalised medicine: maintenance therapy in newly diagnosed ovarian cancer. 17:00 – 18:15 UTC

16:00 – 17:00 UTC CHANNEL 3

SURGICAL FILM EDUCATIONAL SESSION: MANAGING COMPLICATIONS

Welcome Chairs: Mario Leitao (USA), Vance Broach (USA)

Minimally Invasive Management of Vascular Injury During Gynecologic Surgery Jamie Bakkum-Gamez (USA)

Endoscopic Management of Anastomotic Leak Robin Mendehlson (USA)



Management of Lower Urinary Tract Injury – Minimally Invasive Ureteral Reimplantation Lauren Prescott (USA)

Near Infrared Imaging to Assess Bowel Perfusion Following Rectal Anastomosis: Lea Moukarzel (USA)


FRIDAY, SEPTEMBER 11

FRIDAY, SEPTEMBER 11, 2020 11:00 – 17:00 UTC CHANNEL 1

PLENARY III: ORAL ABSTRACT PRESENTATIONS 11:00 – 12:00 UTC

11:00 Welcome

11:01 IGCS20_1420: The learning curve of robot-assisted laparoscopy has impact on the oncological outcomes of early stage cervical cancer patients I. Baeten, J. Hoogendam, H. Schreuder, I. Jürgenliemk-Schulz, R. Verheijen, R. Zweemer, K. Gerestein

11:09 IGCS20_1039: Oncologic Outcomes and Role of Adjuvant Therapy in Endometrial Cancer Patients with Low Volume Metastasis in the Sentinel Lymph Nodes: An International Multi-Institutional Study. K. Ghoniem, G. Dinoi, A. Larish, X. Zhou, M. AlHilli, S. Wallace, C. Wohlmuth, G. Baiocchi, N. Tokgozoglu, F. Raspagliesi, A. Buda, V. Zanagnolo, I. Zapardiel, N. Jagasia, R. Giuntoli, A. Glickman, M. Peiretti, M. Lanner, E. Chacon, J. Di Guilmi, A. Pereira, E. Faron, A. Fishman, C. Nitschmann, S. Parker, A. Joehlin-Price, B. Lees, A. Covens, L. De Brot, C. Taskiran, G. Bogani, C. Paniga, F. Multinu, A. Hernandez-Gutierrez, A. L. Weaver, M. E. McGree

11:17 Distillation Floor Backes (USA)

11:22 IGCS20_1308: Oncolytic Vaccinia (Olvi-Vec) Primed Immunochemotherapy in Platinum-Resistant/Refractory Ovarian Cancer R. Holloway, A. Mendivil, J. Kendrick, L. Abaid, J. Brown, C. Fitzsimmons, J. Kennard, M. King, J. LeBlanc, K. Lopez, M. Manyam, N. McKenzie, K. Mori, A. Stephens, S. Ahmad

11:30 IGCS20_1440: Efficacy on Individualized Starting Dose (ISD) and Fixed Starting Dose (FSD) of Niraparib per Investigator-Assessment (IA) in Newly Diagnosed Advanced Ovarian Cancer (OC) W. Graybill, M. Mirza, A. González-Martin, D. O'Malley, L. Gaba, O.W.S. Yap, E. Guerra, P.G Rose, J. Baurain, S. Ghamande, H. Denys, E. Prendergast, C. Pisano, P. Follana, E.I. Braicu, P.M. Calvert, J. Korach, Y. Li, D. Gupta, B.J. Monk

11:38 Distillation Asima Mukhopadhyay (India)





MASTER SESSION: OVARIAN CANCER 12:00 – 14:30 UTC

12:00 Welcome Chairs: Robert Coleman (USA), Nicoletta Colombo (Italy), Douglas Levine (USA)

12:05 How to Subclassify Ovarian Carcinoma into Hystotypes & Molecular Subtypes? Martin Koebel (Canada)

12:15 TRUST Update Sven Mahner (Germany)

12:25 NACT Proponent Anna Fagotti (Italy)

12:35 PDS Proponent Dennis Chi (USA)

12:45 Discussion

13:00 Vignette Presentation Robert Coleman (USA)

13:05 HRD Positive David O’Malley (USA)

13:15 RP BRCA Neg Shannon Westin (USA)

13:25 Platinum Sensitive Recurrence at 12 Months: What’s next? Who Benefits from PARP in the Recurring Setting? Rosalind Glasspool (UK)

13:35 Discussion

13:45 Molecular Testing for Initial Therapy; Beyond BRCA Charlie Gourley (UK)

13:55 Biomarkers for Immunotherapy Response Brad Nelson (Canada)

14:05 Discussion

INDUSTRY SYMPOSIA: Novocure The Role of Tumor Treatment Fields in the Management of Recurrent Ovarian Cancer 14:30 – 16:00 UTC



INDUSTRY SYMPOSIA: Intuitive Surgical Perspectives on the place of da Vinci robotic assisted surgery in the surgical management of endometrial cancer patients 16:00 – 17:00 UTC

WOMEN4WOMEN CONCERT 17:00 – 18:00 UTC

12:00 – 17:00 UTC CHANNEL 2

DEBATE YOUR COLLEAGUE: HIPEC IN OVARIAN CANCER-READY FOR PRIMETIME? 12:00 – 13:00 UTC 12:00 Opening Comments

Moderator: Keiichi Fujiwara (Japan)

12:05 Pro Willemien van Driel (The Netherlands)

12:20 Rebuttal Christian Marth (Austria)

12:23 Con Christian Marth (Austria)

12:38 Rebuttal Willemien van Driel (The Netherlands)

12:41 Comments Keiichi Fujiwara (Japan)


TUMOR BOARD

13:00 – 14:30 UTC

Chairs: R. Wendel Naumann (USA), Donal Brennan (Ireland) Panelists: Gian Franco Zannoni (Italy), Carien Creutzberg (The Netherlands), Matthew Powell (USA), Isabelle Ray-Coquard (France), Linda Mileshkin (Australia)

13:00 Welcome R. Wendel Naumann (USA)



13:03 Case Presentation & Live Poll R. Wendel Naumann (USA)

13:09 Pathology Review Gian Franco Zannoni (Italy)

13:14 Polling

13:15 Discussant Carien Creutzberg (The Netherlands)

13:23 Discussant Matthew Powell (USA)

13:30 Case 2 Donal Brennan (Ireland)

13:36 Pathology Review & Live Poll Gian Franco Zannoni (Italy)

13:41 Polling

13:45 Discussant Isabelle Ray-Coquard (France)

14:00 Case 3 R. Wendel Naumann (USA)

14:06 Pathology Review & Live Poll Gian Franco Zannoni (Italy)

14:11 Polling

14;15 Discussant Linda Mileshkin (Australia)

14:29 Closing Comments Donal Brennan (Ireland)

INDUSTRY SYMPOSIA: GlaxoSmithKline PARP Inhibitors in the Maintenance Treatment of Advanced Ovarian Cancer: Shared Decision Making, Patient Perspectives 14:30 – 16:00 UTC



12:00 – 13:30 UTC CHANNEL 3

SENTINAL LYMPH NODE BIOPSY IN GYNECOLOGIC ONCOLOGY SURGICAL FILMS This session is presented in partnership with the Society of European Robotic Gynaecological Surgery

Chairs: Henrik Falconer (Sweden), Thomas Ind (UK)

Welcome & Introductions Henrik Falconer (Sweden)

Methodology: Green vs. Blue, Injection Technique

Robert Holloway (USA)

SLN in Endometrial Cancer

Jan Persson (Sweden)

SLN in Cervical Cancer

Fabrice Lecuru (France)

Troubleshooting: Tips & Tricks

Emma Rossi (USA)

Closing Comments Thomas Ind (UK)

12:00 – 14:30 UTC CHANNEL 4

PREINVASIVE DISEASE OF THE LOWER GENITAL TRACT

Chairs: Mila Salcedo (Brazil), Joseph Ng (Singapore), Kathleen Schmeler (USA), Ida Ismail-Pratt (Singapore)

Welcome & Introductions

Cervical Cancer Prevention Overview & HPV Vaccination Kathleen Schmeler (USA)

Using IFCPC Terminology to Report & Diagnose CIN James Bentley (Canada)

Cervical Anatomy, Colposcopy, & Cervical Biopsy Ida Ismail-Pratt (Singapore)



Management of CIN: LLETZ/LEEP Mila Salcedo (Brazil)

Management of CIN: Ablative Therapies Neerja Bhatla (India)

Diagnosis & Management of VIN/VAIN Joseph Ng (Singapore)


SATURDAY, SEPTEMBER 12

SATURDAY, SEPTEMBER 12, 2020 11:00 – 16:00 UTC CHANNEL 1

MASTER SESSION: VULVAR CANCER 11:00 – 12:30 UTC

Chairs: Michael Höckel (Germany), Benedetti Panici (Italy), Ate van der Zee (The Netherlands)

11:00 Current Insights in the Etiology & Pathogenesis of Vulvar Cancer: HPV Infection - Predisposing Conditions - Premalignant Disease - Overt Malignancy Joanne de Hullu (The Netherlands)

11:30 Debate: Early Stage Vulvar Cancer: An Overview of Current Standard of Surgical Care vs Cancer Field Surgery for Vulvar Carcinoma as Alternative Approach Maaike Oonk (The Netherlands) vs Nadja Dornhöfer (Germany)

12:00 Role of Adjuvant Therapy in Primary Treatment of Vulvar Cancer Linn Wölber (Germany)

PRESIDENTIAL PLENARY IV 12:30 – 13:30 UTC

12:30 Presidential Address Roberto Angioli (Italy)

12:45 World Ovarian Cancer Coalition Global Ovarian Cancer Charter Launch Elisabeth Baugh (Canada), Frances Reid (UK)

12:52 Global Outreach & Engagement Initiatives of the International Gynecologic Cancer Society Dicey Jackson Scroggins (USA)

13:00 Business Meeting Roberto Angioli (Italy)

MASTER SESSION: UTERINE CANCER 13:30 – 15:30 UTC

Chairs: Pernille Jensen (Denmark), Andrea Mariani (USA), Matthew Powell (USA)

13:30 Sentinel LN is Positive on Frozen Section: Full Dissection vs "Why did I Send for Frozen?" Edward Tanner (USA)

13:45 Sufficient Evidence to Implement SLN in Women with EC, High Risk Histology - Risk of Missing Paraaortic LN Metastases Emma Rossi (USA)



14:00

Case Set Up with Controversy Andrea Mariani (USA)

14:05 What to do with ITC and Micro Metastasis in SLN on Final Pathology Marie Plante (Canada)

14:17 No Need for Adjuvant Treatment or Send for the Chemo & Radiation? Or in the Middle? Floor Backes (USA)

14:30 Debate: Molecular Profiling for Postop Risk Stratification & Adjuvant Treatment Decisions of Women with Early Stage EC Ready: Jessica McAlpine (Canada) vs Not Ready: Remi Nout (The Netherlands) Panelist: Anuja Jhingran (USA)

15:00 Where are We Today & Where are We Going in the Treatment of Women with Advanced/Recurrent EC? Mansoor Mirza (Denmark)

INDUSTRY SYMPOSIUM: Immunogen Promising Agents in Development for Recurrent Ovarian Cancer 15:30 – 16:30 UTC

11:00 – 16:15 UTC CHANNEL 2

IMMUNOTHERAPY IN THE MANAGEMENT OF GYNECOLOGIC CANCERS 11:00 – 12:30 UCT

Chair: Amir Jazeri (USA)

11:00 Welcome & Introduction Amir Jazaeri (USA)

11:05 Current State of Immunotherapy in Ovarian Cancer Kosei Hasegawa (Japan)

11:23 Current State of Immunotherapy in Endometrial Cancer Rebecca Kristeleit (UK)

11:41 Management of irAEs Amir Jazaeri (USA)

11:59 Ongoing Trials & Future of IO Ramez Eskander (USA)




CANCER CARE IN AFRICA 13:30 – 14:30 UTC

Chairs: Elkanah Omenge Orang'o (Kenya), Jane Namugga (Uganda)

13:30 Welcome & Introductions Omenge Orang'o (Kenya)

13:33 Union for International Cancer Control Julie Torode (Switzerland)

13:43 National Cancer Institute Edward Trimble (USA)

13:53 World Health Organization Groesbeck Parham (USA/Zambia), Elena Fidarova (Austria)

14:03 IGCS Partnerships with Mentorship & Training Omenge Orang'o (Kenya)

14:05 Ovarian Cancer in SSA Dawit Worku (Ethiopia)

14:15 Cervical Cancer Management when Radiotherapy is Scarce Jane Namugga (Uganda)

14:25 Closing Comments Omenge Orango'o (Kenya)

GTD: STATE OF THE ART MANAGEMENT OF HIGH RISK, ULTRA-HIGH RISK, & RECURRENT/REFRACTORY DISEASE This session is presented in partnership with the International Society for the Study of Trophoblastic Disease (ISSTD). 14:30 – 15:30 UTC

Chairs: John Soper (USA), Neil Horowitz (USA) Panelists: Pierre-Adrien Bolze (France), Antonio Braga (Brazil), Matthew Winter (UK), Hextan Ngan (Hong Kong)

14:30 Welcome & Introductions Neil Horowitz (USA)

14:32 Case Presentation John Soper (USA)

14:37 Panel Discussion

14:52 Case Presentation Neil Horowitz (USA)




15:12 Case Presentation Omenge Orang'o (Kenya)


INDUSTRY SYMPOSIUM: Myriad Session title to be announced 15:30 – 16:15 UTC

11:00 – 12:30 UTC CHANNEL 3

SURGICAL FILMS: OVARIAN CANCER 11:00 – 12:30 UTC

Chairs: Christina Fotopoulou (UK), Reitan Ribeiro (Brazil)

Welcome & Introductions Reitan Ribeiro (Brazil)

Overview Christina Fotopoulou (UK)

How to Properly Perform the Fagotti Score in Diagnostic Laparoscopies Prior to Surgical Ovarian Debulking Anna Fagotti (Italy)

Tips & Tricks for a Safe Colorectal Anastomosis Reitan Ribeiro (Brazil)

Mesenteric Peritoneal Implants Resection Christina Fotopoulou (UK)

Diaphragmatic Reconstruction Techniques Bernard Park (USA)

Cardiophrenic Lymph Nodes Resection Robert Bristow (USA)



SURGICAL FILM EDUCATIONAL: ENDOSCOPY This session is presented in partnership with the European Society of Gynecological Endoscopy (ESGE). 13:30 – 15:30 UTC

Chairs: Giovanni Scambia (Italy), Sven Becker (Germany)

Hysteroscopic Resection for Fertility-Sparing Approach in Early Endometrial Cancer Patients Attilio Di Spiezio Sardo (Italy)

SLN In Endometrial Cancer: Tips & Tricks Francesco Fanfani (Italy)

Systematic Pelvic Lymphadenectomy Morva Tahmasbi Rad (Germany)

Retroperitoneal Laparoscopic Lymphadenectomy for Locally Advanced Cervical Cancer Vito Chiantera (Italy)

MIS For Pelvic & Aortic Bulky Nodes Resection Ramon Rovira (Spain)

Single-Site Robotic Approach for Endometrial Cancer Patients Liliana Mereu (Italy)

11:00 – 16:30 UTC CHANNEL 4

THE ROLE OF THE GYNECOLOGIC ONCOLOGIST IN THE MANAGEMENT OF OBSTETRICAL DISASTERS This course is presented in partnership with the Middle East and Mediterranean Association of Gynecologic Oncologists (MEMAGO) and the Lebanon Gynecologic Oncology Group (LGOG). 11:00 – 12:30 UTC

Chairs: David Atallah (Lebanon), Muhieddine Seoud (Lebanon), Ali Ayhan (Turkey), Faruk Kose (Turkey)

Introduction, Case Presentation Muhieddine Seoud, David Atallah (Lebanon)

PAS FIGO Classification Muhieddine Seoud (Lebanon)

Massive Transfusion Protocols Leigh Cantrell (USA)



Place for Conservative Management in PAS Ahmet Göçmen (Turkey)

Radical Management of PAS: Tips & Tricks David Atallah (Lebanon)

The Gyn Onc in the Management of Postpartum Hemorrhage of Out PAS Mehmet Mutlu Meydanli (Turkey)

ORAL FEATURED POSTERS 13:30 – 14:30 UTC

13:30 Welcome Thomas Herzog (USA)

13:31 IGCS20_1018: Development of a triage tool including HE4, D-dimer, and fibrinogen for the assessment of women presenting with pelvic masses K. McKendry, S. Duff, S. O'Toole

13:36 IGCS20_1067: Molecular Subtype Diagnosis of Endometrial Carcinoma: Comparison of NGS Panel and Promise Classifier J. Huvila, K. Orte, P. Vainio, T. Mettälä, T. Joutsinimi, S. Hietanen

13:41 IGCS20_1226: Screening for cervical cancer in women under the age of 25: a cross-sectional study at an University Hospital in Minas Gerais – Brazil L. Barbosa, B. Napoleão, M. Franco, E. Ferreira-Filho, S. Nicolau

13:46 IGCS20_1486: Clinical management of gynecologic cancer patients during COVID-19 pandemia: the experience of Day Hospital Tumori Femminili of Fondazione Policlinico Agostino Gemelli, IRCCS E. Palluzzi, G. Corrado, G. Bolomini, L. Vertechy, C. Bottoni, E. Teodorico, C. Marchetti, M. Distefano, G. Scambia, G. Ferrandina

13:51 IGCS20_1102: Prognostic Value and Association with Veliparib Benefit of Modeled CA-125 Elimination Kinetics (KELIM) in Patients with Newly Diagnosed Ovarian Cancer: Analysis from the VELIA/GOG-3005 Study B. You, G. Fleming, M. Bookman, K.N. Moore, K.D. Steffensen, R.L. Coleman

13:46 IGCS20_1165: Quantitative evaluation of lymph-vascular space invasion (LVSI) in patients affected by endometrial cancer: prognostic and clinical implications S. Restaino, L. Tortorella, E. Perrone, G. Monterossi, A. Gioè, I. Capasso, E. La Fera, G. Dinoi, G. Scambia, F. Fanfani, G. Zannoni, V. Chiantera

14:01 IGCS20_1184: A training program to build capacity for cervical cancer prevention in Mozambique M. Salcedo, M. Varon, E. Baker, N. Osman, E. David, R. Rangeiro, D. Changule, V. Andrade, C.M. Oliveira, A. Neves, J. Carns, C. Lorenzoni, K.M. Schmeler



14:06 IGCS20_1063: Development of a nomogram to predict interval debulking surgery feasibility when primary cytoreduction is not an option. A. Rosati, C. Marchetti, F. DeFelice, V. Tranquillo, V. Iacobelli, L. Quagliozzi, V. Salutari, G. Scambia, A. Fagotti

14:11 IGCS20_1007: Integrated model of patient factors, resectability score and surgical complexity index to predict surgical outcome in debulking surgery for advanced ovarian cancer L. Hogen, S. LAFRAMBOISE, T. May, A. Ding, M. Bernardini

14:16 IGCS20_1214: Increase in Uterine Serous Carcinoma: Will it Surpass Uterine Endometrioid Cancer? A population analysis of 720,984 uterine cancer patients. C. Liao, K. Tran, M. Richardson, K. Darcy, C. Tiao, C.A. Hamilton, L. Maxwell, A. Mann, D.S. Kapp, J. Chan

14:21 IGCS20_1450: Clinicopathologic Predictors Of Early Relapse In Advanced Epithelial Ovarian Cancer; Development Of Prediction Models Using Nationwide Data S. Said, R. Bretveld, H. Koffijberg, G. Sonke, R.F.P.M. Kruitwagen, J.A. de Hullu, A.M. van Altena, S. Siesling, M.A. van der Aa

14:26 Closing Comments Thomas Herzog (USA)

AN UPDATE ON THE WHO CLASSIFICATION OF TUMORS OF THE FEMALE GENITAL TRACT This course is presented in partnership with International Society of Gynaecological Pathologists (ISGyP) and the European Society of Pathology (ESP). 14:30 – 15:30 UTC

Genetic Tumor Syndromes of The Genital Female Tract Gian Franco Zannoni (Italy)

An Update on The WHO Classification of Tumors of The Female Genital Tract: Endocervical Adenocarcinoma Xavier Matias-Guru (Spain)

Uterine Sarcomas: Novel Aspects Sigurd Lax (Austria)


SUNDAY, SEPTEMBER 13

SUNDAY, SEPTEMBER 13, 2020 2:00 – 6:00 UTC CHANNEL 1

CANCER FIELD SURGERY FOR GYNECOLOGIC MALIGNANCIES 2:00 – 3:00 UTC

Chairs: Rainer Kimmig (Germany), Michael Höckel (Germany)

2:00 Introduction Rainer Kimmig (Germany)

2:05 Overview on Ontogenetic Cancer Field Theory Michael Höckel (Germany)

2:20 Progression of Cancer by Reverse Ontogenesis Ulrich Behn (Germany)

2:30 Cancer Field Surgery for Lower Genital Tract Cancer Michael Höckel (Germany)

2:45 Cancer Field Surgery for Upper Genital Tract Cancer Rainer Kimmig (Germany)

MASTER SESSION: CERVIX CANCER 3:00 – 5:00 UTC Chairs: Bradley Monk (USA), Mary McCormack (UK), Ana Oaknin (Spain)

3:00 Introduction

3:05 Histologic Subtypes & Molecular Features Kathleen Moore (USA)

3:20 Staging Jalid Sehouli (Germany)

3:35 State of the Science in Radiation Therapy Alexandra Taylor (UK)

3:50 Addition Systemic Therapy to Radiation (CCRT) Linda Mileshkin (Australia)

4:05 Firstline Treatment of Metastatic Disease Leslie Randall (USA)



4:20 Second-Line Metastatic Disease Krishnansu Tewari (USA)

4:35 Clinical Care in Under-Resourced Settings & How To Start A Clinical Trials Program Marie Plante (Canada)

4:50 Discussion

PLENARY V: ORAL ABSTRACT PRESENTATIONS 5:00 – 6:00 UTC

5:00 Welcome Moderators: David Atallah (Lebanon), Andreas Obermair (Australia)

5:01 IGCS20_1271: Phase II trial evaluating efficacy and safety of standard of care with or without bevacizumab in platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer N. Nishikawa, T. Shoji, T. Enomoto, M. Abe, A. Okamoto, T. Saito, T. Oishi, S. Nagase, M. Mori, Y. Inokuchi, S.K. Kamiura, T. Sugiyama

5:09 IGCS20_1306: Randomized Double-Blind Placebo Controlled Trial of Frontline Maintenance Vigil Immunotherapy (VITAL study) in Stage III/IV Ovarian Cancer: Efficacy Assessment in BRCA1/2-wt Patients R. Rocconi, E. Grosen, S. Ghamande, J. Chan, M. Barve, J. Oh, D. Tewari, P. Morris, E. Stevens, J. Bottsford-Miller, M. Tang, P. Aaron, G. Wallraven, E. Bognar, L. Manning, J. Nemunaitis, B. Slomovitz, T. Herzog, B. Monk, R. Coleman

5:17 IGCS20_1101: Quality-adjusted (QA) progression-free survival analyses of veliparib + carboplatin/paclitaxel (CP) vs CP alone in patients with newly diagnosed ovarian cancer A. Alvarez Secord, M. Bookman, R. Coleman, M. Dinh, N. Khandelwal, K. Benjamin, R. Kamalakar, D. Sullivan, D. Cella

5:25 Distillation

5:30 IGCS20_1131: Safety and patient-reported outcomes in patients receiving niraparib in the PRIMA/ENGOT-OV26/GOG-3012 trial G. Freyer, B. Pothuri, S. Han, D. Chase, B. Monk, F. Heitz, R. Burger, L. Gaba, L. Van Le, E. Guerra, D. Bender, J. Korach, N. Cloven, C. Churruca, P. Follana, P. DiSilvestro, J.F. Baurain, K. Jardon, C. Pisano, U. Peen, J. Maenpaa, P. Hoskins, E. Bacque, Y. Li, L. Eliason, A. González-Martín

5:38 IGCS20_1207: Efficacy of maintenance olaparib plus bevacizumab by biomarker status in clinical higher- and lower-risk patients with newly diagnosed, advanced ovarian cancer in the PAOLA-1 trial P. Harter, D. Petran, G. Scambia, E. Ortega, I. Tsibulak, S. Nagao, I. Vergote, J. Meunier, F. Priou, R. Sverdlin, T. Milenkova, I. Ray-Coquard

5:46

5:59

Question & Answer

Closing Comments



2:00 – 4:00 UTC CHANNEL 2

ORAL FEATURED POSTERS 2:00 Welcome

Moderators: Jessica McAlpine (Canada), David Tan (Singapore), Alexey Shevchuk (Russia)

2:01

IGS20_1248: Overall Survival After Surgical Staging by Lymph Node Dissection Versus Sentinel Lymph Node Biopsy In Endometrial Cancer: A National Cancer Database study. S. Garzon, A. Mariani, C. Day, E. B. Habermann, C.L. Langstraat, G.E. Glaser, A. Kumar, A. Larish

2:07 IGCS20_1082: Long-term survival outcomes of intravenous vs intraperitoneal chemotherapy in the treatment of advanced ovarian cancer R. Kim, M. Maganti, M. Bernardini, S. Laframboise, S. Ferguson, T. May

2:13 IGCS20_1170: Can conisation specimens predict sentinel lymph node status in early-stage cervical cancer? A SENTICOL group study J. Mereaux, V. Balaya, B. Guani, L. Magaud, H. Bonsang-Kitzis, C. Ngo, F. Lecuru, P. Mathevet

2:19 Questions & Discussion Moderator: Jessica McAlpine (Canada)

2:29 IGCS20_1222: COVID-19: A review of the impact of the pandemic on ovarian cancer patient advocacy organizations from around the world F. Reid, C. MacKay

2:35 IGCS20_1127: Impact of COVID-19 in Gynecologic Oncology: a Nationwide Italian Survey G. Bogani, G. Apolone, A. Ditto, G. Scambia, P. Benedetti Panici, R. Angioli, S. Pignata, S. Greggi, P. Scollo, D. Mezzanzanica, M. Franchi, V. Di Donato, G. Valabrega, G. Ferrandina, I. Palaia, A. Bergamini, L. Bocciolone, A. Savarese, F. Ghezzi, J. Casarin, V. Trojano, V. Chinatera, G. Giorda, M. Malzoni, G. Salerno, E. Sartori, A. Testa, G.F. Zannoni, F. Zullo, E. Vizza, G. Trojano, A. Chiantera, F. Raspagliesi

2:41 IGCS20_1162: Patterns of Recurrence in Vulvar Cancer: A Nationwide Population-based Study D. Zach, E. Åvall Lundqvist, H. Åvall Lundqvist, J. Hemming, K. Hellman, A. Flöter Rådestad

2:46 Questions & Discussion Moderator: David Tan (Singapore)

2:57 IGCS20_1484: Endometrial cancer: laparoscopy vs robotic surgery. A large single-institution retrospective analysis. E. Perrone, I. Capasso, A. Gioè, S. Restaino, E. Distefano, G. Dinoi, G. Scambia, F. Fanfani

3:03 IGCS20_1114: Meta-analysis comparing influence of no adjuvant treatment, postoperative radiotherapy and/or chemotherapy on survival in patients after primary surgery including lymphadenectomy for early stage uterine carcinosarcoma V. Student, S. Garzon, L. Prokop, M.H. Murad, I. Sedlakova, A. Mariani



3:09 IGCS20_1254: Therapeutic role of pelvic and para-aortic lymphadenectomy in apparent early stage epithelial ovarian cancer. N. Bizzarri, A. Du Bois, R. Fruscio, F. De Felice, P. De Iaco, J. Casarin, E. Vizza, V. Chiantera, G. Corrado, S. Cianci, P. Harter, B. Ataseven, M. Bommert, A.M Perrone, S. Magni, D. Ferrari, B. Zambetti, G. Scambia, A. Fagotti

3:15 Questions & Discussion Moderator: Alexey Shevchuk (Russia)

3:26 IGCS20_1319: Prevalence and prognosis of Lynch syndrome and sporadic mismatch repair deficiency in the combined PORTEC-1,-2 and -3 endometrial cancer trials C. Post, E. Stelloo, V. Smit, D. Ruano, C.M. Tops, L. Vermij, T.A. Rutten, I.M. Jürgenliemk-Schulz, L.C. Lutgens, J.J. Jobsen, R.A. Nout, E.J. Crosbie, M.E. Powell, L. Mileshkin, A. Leary, P. Bessette, S.M. de Boer, N. Horeweg, T. van Wezel, T. Bosse, C.L Creutzberg

3:32 IGCS20_1217: Comprehensive molecular assessment of mismatch repair deficiency in Lynch-associated ovarian cancers using next-generation sequencing (NGS) panel S. Kim, L. Oldfield, A. Tone, A. Pollette, E. Van de Laar, S. Pederson, J. Wellum, B. Clarke, T. Pugh, S. Ferguson

3:38 IGCS20_1189: Risk Factors Associated with Increasing Incidence of Uterine Cancer After Correcting for Hysterectomy C. Liao, K. Tran, M. Richardson, K. Darcy, C. Tian, C.A. Hamilton, L. Maxwell, A. Mann, D.S. Kapp, J.K. Chan

3:44 IGCS20_1179: Survival outcomes in endometrial cancer patients having lymphadenectomy, sentinel node mapping followed by lymphadectomy and sentinel node mapping alone: long-term results of a propensity-matched analysis G. Bogani, C. Pinelli, A. Ditto, J. Casarin, F. Ghezzi, F. Raspagliesi

3:50 Questions & Discussion Moderator: To be announced



SURGICAL FILMS: CERVICAL CANCER & FERTILITY PRESERVATION

Chair: Jae-Weon Kim (Rep. of Korea)

Welcome & Introductions Jae-Weon Kim (Rep. of Korea)

Total Laparoscopic Radical Hysterectomy with No-Look No-Touch Technique Hiroyuki Kanao (Japan)



Combined Laparoscopic-Vaginal Technique for Radical Hysterectomy Christhardt Köhler (Germany)

Simple Trachelectomy as a Fertility-Sparing Treatment for Low Volume Early-Stage Cervical Cancer Allan Covens (Canada)

Radical Trachelectomy - Abdominal Approach Jin Li (China)

Radical Trachelectomy - Laparoscopic or Robotic Approach Jeong-Yeol Park (Rep. of Korea)

Closing Comments


KOREAN SOCIETY OF GYNECOLOGIC ONCOLOGY REGIONAL PROGRAM 6:00 – 7:30 UTC

Chairs: Seung-Cheol Kim, Jae-Weon Kim, Young-Tak Kim, Young Tae Kim

PARPi & ICI in Clinics & Research

6:00 BRCA: regional consideration in Korea Myong-Cheol Lim (Rep. of Korea)

6:15 Candidate Biomarker of PARP Inhibitor & ICI In Ovarian Cancer Jung-Yun Lee (Rep. of Korea)

6:30 Discussion David Tan (Singapore)


Less Radical Surgery: The New Standard of Care?

6:40 Visceral Segmental Serosectomy In Debulking Ovarian Cancer Surgery Hee-Seung Kim (Rep. of Korea)

6:55 Discussion Ji Won Park (Rep. of Korea)

7:00 Fertility-preserving surgery in cervical cancer in post-LACC era Jeong-Yeol Park (Rep. of Korea)



7:15 Discussion Jin Li (China)


JAPANESE SOCIETY OF GYNECOLOGIC ONCOLOGY REGIONAL PROGRAM WHAT WE LEARNED FROM OCCC – FOOTPRINT OF JSGO STUDIES 7:30 – 9:00 UTC

Chair & Moderator 1: Kimio Ushijuma (Japan)

7:30 Why in Japan? The high incidence of OCCC: A large cohort study Fuminori Taniguchi (Japan)

7:45 Questions & Discussion

7:48 From Pathological View: Characteristics of OCCC Different From HGSC Daichi Maeda (Japan)


Moderator 2: Aikou Okamoto (Japan)

8:06 What Happened to Endometriosis: Way To OCCC Ken Yamaguchi (Japan)


8:24 Strategy Against OCCC: Surgery & Chemo Hiroaki Kajiyama (Japan)


8:42 Future Perspectives Noriomi Matsumura (Japan)



RECOGNITION, ACKNOWLEDGEMENTS, AND INDUSTRY SUPPORT

INDUSTRY SPONSORS

The Organizing Committee of IGCS 2020 would like to express its gratitude and acknowledge the following companies and organizations for their generous support. More information about the sponsors can be found within the Meeting Portal.

Platinum Level Sponsors

Gold Level Sponsors

Bronze Level Sponsors

Sponsor

Silver Level Sponsor

Africa South African Society of Gynecologic Oncology

Latin America Argentinian Association of Gynecologic Oncology Colombian Association of Gynecologic Oncology Chilean Society of Gynecologic Oncology Peruvian Society of Gynecological Oncology The National Institute of Neoplastic Diseases (Peru) Mexican College of Gynecologic Oncologists

Eastern Europe Belarusian Society of Oncologists (Gyn Onc Branch) Russian Society of Oncologists in Cancer of Reproductive Systems

Eastern Asia Chinese Gynecologic Cancer Society

Central Asia Association of Oncologists of the Republic of Kazakhstan Association of Oncologists of Uzbekistan Kyrgyzstan Tajikistan

South East Asia Indonesian Society of Gynecologic Oncology Malaysian Gynecological Cancer Society Society of Gynecologic Oncologists of the Philippines Thai Gynecologic Cancer Society

Middle East Israeli Society of Gynecological Oncology Middle East and Mediterranean Association of Gynecologic Oncologists Pan-Arabian Research Society of Gynecologic Oncology

International The International Society of Gynecological Pathologists

STRATEGIC ALLIANCE PARTNERS

Through the IGCS Strategic Alliance Partnership, regional groups and societies strengthen their voice in the global arena and participate in strategic conversations with the IGCS leadership and other key global leaders.

ORGANIZATIONAL PARTNERS

STRATEGIC ADVOCACY PARTNERS

2020-2022 Council

OFFICERS

COUNCIL MEMBERS

President Dr. Robert Coleman Gynecologic Oncologist Houston, TX, USA

President Elect Dr. Keiichi Fujiwara Gynecologic Oncologist Saitama, Japan

Vice President Dr. Jae-Weon Kim Gynecologic Oncologist Seoul, Rep. of Korea

Secretary-treasurer Dr. Anuja Jhingran Radiation Oncologist Houston, TX, USA

Secretary-Treasurer Elect Dr. Rainer Kimmig Gynecologic Oncologist Essen, Germany

Immediate Past President Dr. Roberto Angioli Gynecologic Oncologist Rome, Italy

Dr. Greta Dreyer Gynecologic Oncologist Arcadia, Pretoria, South Africa

Dr. Rhonda Farrell Gynecologic Oncologist Sydney, Australia

Dr. Blake Gilks Pathologist Vancouver, BC, Canada

Dr. Rosalind Glasspool Medical Oncologist Glasgow, Scotland, UK

Dr. Mario Leitao, Jr. Gynecologic Oncologist New York, NY, USA

Dr. Daniela Luvero Gynecologic Oncologist Rome, Italy

Dr. Joseph Soon-Yau Ng Gynecologic Oncologist Singapore

Dr. Rene Pareja Gynecologic Oncologist Medellín, Colombia

Dr. Alexandra Taylor Radiation Oncologist London, England, UK

EX-OFFICIO COUNCIL MEMBERS

Mentorship & Training Committee Chair

Dr. Kathleen Schmeler Gynecologic Oncologist Houston, TX, USA

Education Committee Chair

Dr. Ritu Salani Gynecologic Oncologist Columbus, OH

Chief Executive Officer

Mary Eiken IGCS CEO Chicago, IL

We gratefully acknowledge the Officers & Council Members who are ending their terms in 2020.

Outgoing Officers: Past President: Dr. Michael Quinn (Australia) Vice President: Dr. Marie Plante (Canada) Secretary-Treasurer: Dr. Andreas Obermair (Australia)

Outgoing Council Members: Dr. Vivek Arora (Australia)

Dr. Mauricio Augusto Silva Magalhães Costa (Brazil) Dr. Rainer Kimmig (Germany) Dr. Remi Nout (The Netherlands) Dr. Robert Soslow (USA)

2020 AWARD RECIPIENTS

Lifetime Achievement Award

Nicoletta Colombo, MD, PhD

European Institute of Oncology Milan, Italy

For her exemplary leadership in multiple gynecologic oncology organizations, commitment to science, research and clinical trials.

Rahel Ghebre, MD, MPH

University of Minnesota Minneapolis, MN, USA

For her mentorship and leadership with gynecologic oncology sub-specialty training programs in Ethiopia, specifically at Addis Ababa University and initiating a program at St. Paul's Millennium Medical College.

Monica Bacon, RN

Queen's University Ontario, Canada

For her lifelong dedication to women’s health and serving the gynecologic cancer community though nursing, clinical trial coordination and international team building, advocacy, and volunteerism.

Excellence in Teaching Award

2020 AWARD RECIPIENTS

Distinguished Advocacy Award

Nathalie Dauphin McKenzie & Innovating Health International USA/Haiti For courageous, ongoing advocacy for survivors-patients in the USA and Haiti, including traveling to Haiti several times a year—at great personal risk—to perform life-saving surgeries (otherwise unavailable) and to train oncologists to do the same, currently primarily through Innovating Health International, a Port-au-Prince based women’s cancer center, where no patient is ever turned away because of treatment costs innovatinghealthinternational.org

Ovarian Cancer Research Alliance USA For dedicated service to advocate and research communities, as the largest global, non-government funder of ovarian cancer research, having raised over $100 million for research/services and developed and conducted extensive advocacy programs including Survivors Teaching Students® through which ovarian cancer survivors and family members have trained/reached nearly 100,000 medical and other health professions students ocrahope.org

Runcie Chidebe & Project PINK BLUE Nigeria For outstanding advocacy throughout Nigeria and in global forums, including founding Project PINK BLUE—an organization focused on cancer advocacy, oncology training, and research—as well as influencing the establishment of the National Institute for Cancer Research and Treatment, developing numerous programs to serve the most needy, and changing cancer awareness and care throughout Nigeria projectpinkblue.org

2020 IJGC AWARD RECIPIENTS

Gloria Salvo, MD University of Texas, MD Anderson Cancer Center Houston, TX, USA

David Cibula, MD, PhD Charles University & General University Hospital in Prague, First Faculty of Medicine Prague, CZ

Most Downloaded Paper Award For the paper titled

“Updates and management algorithm for neuroendocrine tumors of the uterine cervix”

Editor’s Choice Award For the paper titled

“European Society of Gynaecological Oncology quality indicators for surgical treatment of cervical cancer”

IGCS Staff

Chief Executive Officer Mary Eiken, MS [email protected]

Director of Global Outreach & Engagement Mary (Dicey) Jackson Scroggins, MA

[email protected]

Membership Manager Cathy Fearing

[email protected]

Online Education Manager Mandy Hansen

[email protected]

Mentorship & Training Program Manager Susan Ralph

[email protected]

Communications Manager Debbie Leopold

[email protected]

Social Media Manager Kayla Sharples

[email protected]

Save the Date! August 29– September 2, 2021

Documents

2020 Annual Global Meeting - IGCS xDigital 2020...2020/09/03 · Muhieddine Seoud (Lebanon), Ali Ayhan (Turkey) 12:30— 13:30 Presidential Plenary IV Presidential Address, Advocacy